Have your own idea? Try our Stock Screener
Swiss (SMI) Drug Retail Industry Analysis
UpdatedMay 25, 2026
DataAggregated Company Financials
Companies1
- 7D-7.4%
- 3M26.6%
- 1Y-28.5%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 7.4%, driven by declines from every company within the industry. The industry has fallen 29% in the last year. Looking forward, earnings are forecast to grow by 65% annually.
Industry Valuation and Performance
Has the Swiss Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 May 2026 | CHF 319.9m | CHF 1.1b | -CHF 134,395,000.00 | n/a | -2.4x | 0.3x |
| Wed, 22 Apr 2026 | CHF 349.0m | CHF 1.1b | -CHF 134,395,000.00 | n/a | -2.6x | 0.3x |
| Fri, 20 Mar 2026 | CHF 195.0m | CHF 1.1b | -CHF 134,395,000.00 | n/a | -1.5x | 0.2x |
| Sun, 15 Feb 2026 | CHF 274.1m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.3x | 0.3x |
| Tue, 13 Jan 2026 | CHF 291.8m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.4x | 0.3x |
| Thu, 11 Dec 2025 | CHF 270.9m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.2x | 0.3x |
| Sat, 08 Nov 2025 | CHF 245.9m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2x | 0.2x |
| Mon, 06 Oct 2025 | CHF 297.3m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.5x | 0.3x |
| Wed, 03 Sep 2025 | CHF 311.8m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.6x | 0.3x |
| Fri, 01 Aug 2025 | CHF 369.6m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -3.3x | 0.4x |
| Sun, 29 Jun 2025 | CHF 308.6m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -2.7x | 0.3x |
| Tue, 27 May 2025 | CHF 453.6m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -4x | 0.4x |
| Thu, 24 Apr 2025 | CHF 241.3m | CHF 1.0b | -CHF 97,253,000.00 | n/a | -2.5x | 0.2x |
| Sat, 22 Mar 2025 | CHF 211.3m | CHF 1.0b | -CHF 97,253,000.00 | n/a | -2.2x | 0.2x |
| Mon, 17 Feb 2025 | CHF 239.8m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -2.5x | 0.2x |
| Wed, 15 Jan 2025 | CHF 235.1m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -2.4x | 0.2x |
| Fri, 13 Dec 2024 | CHF 337.9m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -3.5x | 0.3x |
| Sun, 10 Nov 2024 | CHF 475.6m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.9x | 0.5x |
| Tue, 08 Oct 2024 | CHF 410.1m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.2x | 0.4x |
| Thu, 05 Sep 2024 | CHF 486.4m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -5x | 0.5x |
| Sat, 03 Aug 2024 | CHF 563.0m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -4.8x | 0.6x |
| Mon, 01 Jul 2024 | CHF 689.2m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -5.9x | 0.7x |
| Wed, 29 May 2024 | CHF 854.4m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -7.3x | 0.9x |
| Fri, 26 Apr 2024 | CHF 971.0m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -8.3x | 1x |
| Sun, 24 Mar 2024 | CHF 998.6m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -8.5x | 1x |
| Tue, 20 Feb 2024 | CHF 1.1b | CHF 1.6b | -CHF 145,782,000.00 | n/a | -7.4x | 0.7x |
| Thu, 18 Jan 2024 | CHF 840.8m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.8x | 0.5x |
| Sat, 16 Dec 2023 | CHF 812.0m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.6x | 0.5x |
| Mon, 13 Nov 2023 | CHF 506.6m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -3.5x | 0.3x |
| Wed, 11 Oct 2023 | CHF 613.9m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -4.2x | 0.4x |
| Fri, 08 Sep 2023 | CHF 697.4m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -4.8x | 0.4x |
| Sun, 06 Aug 2023 | CHF 590.9m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -3.5x | 0.4x |
| Tue, 04 Jul 2023 | CHF 455.6m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.7x | 0.3x |
| Thu, 01 Jun 2023 | CHF 334.5m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2x | 0.2x |
Price to Earnings Ratio
-2x
Current Industry PE
- There is only one company in the Swiss Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 11% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Swiss Drug Retail compare with similar industries?
| CH Market | 1.72% | |
| Consumer Staples | 0.59% | |
| Food and Staples Retail | -6.25% | |
| Drug Retail | -7.39% | |
| Food Retail | 0% | 0 |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||